NASDAQ: SILO
Silo Pharma Inc Stock Ownership - Who owns Silo Pharma?

Insider buying vs selling

Have Silo Pharma Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Eric WeisblumCEO and President2024-12-132,500$0.84
$2.10kBuy
Eric WeisblumCEO and President2024-11-222,500$0.90
$2.25kBuy
Eric WeisblumCEO and President2024-11-202,500$0.95
$2.38kBuy
Eric WeisblumCEO and President2024-06-124,438$1.11
$4.93kBuy
Eric WeisblumCEO and President2024-06-11562$1.08
$606.96Buy

1 of 1

SILO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SILO insiders and whales buy or sell their stock.

SILO Shareholders

What type of owners hold Silo Pharma Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Eric Weisblum4.19%187,932$202.03kInsider
Renaissance Technologies LLC0.84%37,500$40.31kInstitution
Geode Capital Management LLC0.78%34,948$37.57kInstitution
Ubs Group Ag0.45%20,085$21.59kInstitution
Vanguard Group Inc0.36%16,334$17.56kInstitution
Xtx Topco Ltd0.32%14,563$15.66kInstitution
State Street Corp0.28%12,500$13.44kInstitution
Hrt Financial LP0.26%11,448$12.31kInstitution
Two Sigma Securities LLC0.25%11,375$12.23kInstitution
Virtu Financial LLC0.23%10,430$11.21kInstitution

1 of 2

SILO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SILO4.09%4.30%Net Buying
APM0.87%38.15%
GTBP50.75%49.25%
SXTP4.75%95.25%Net Buying
ATNF4.22%95.78%

Silo Pharma Stock Ownership FAQ

Who owns Silo Pharma?

Silo Pharma (NASDAQ: SILO) is owned by 4.09% institutional shareholders, 4.30% Silo Pharma insiders, and 91.61% retail investors. Eric Weisblum is the largest individual Silo Pharma shareholder, owning 187,932.00 shares representing 4.19% of the company. Eric Weisblum's Silo Pharma shares are currently valued at $199.21k.

If you're new to stock investing, here's how to buy Silo Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.